Hefei Lifeon Pharmaceutical Co., Ltd.

SZSE:003020.SZ

25.2 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 350.796428.847333.618370.753256.711455.974811.817685.153664.961600.609628.617608.357591.089524.715549.094518.091484.161439.526452.514447.89418.3391.921391.921
Cost of Revenue 119.358123.063103.397111.06793.676206.526515.197456.627415.906364.042382.488371.724355.145305.956333.261345.796307.673287.112320.073307.641280.212272.477272.477
Gross Profit 231.438305.784230.221259.685163.035249.448296.62228.526249.055236.568246.129236.633235.944218.76215.833172.295176.488152.413132.441140.25138.088119.444119.444
Gross Profit Ratio 0.660.7130.690.70.6350.5470.3650.3340.3750.3940.3920.3890.3990.4170.3930.3330.3650.3470.2930.3130.330.3050.305
Reseach & Development Expenses 17.07311.95623.54723.92517.13430.2612.53923.85521.20817.98213.19922.96113.80516.68712.4059.5914.914.4494.3720.0016.5115.4665.466
General & Administrative Expenses 51.144-5.28418.046-24.65536.764-5.36615.16419.34233.9-5.98711.666-21.1725.85-3.1859.5298.251-9.507-2.7326.174-14.6487.7667.7597.759
Selling & Marketing Expenses 198.439212.132158.409171.75594.887148.444183.366138.642158.218146.991162.524154.162162.014145.962143.103108.86112.95386.09385.90483.2993.96673.10173.101
SG&A 176.922234.082176.455182.236131.651143.078198.53166.8192.117141.003174.19132.992187.864142.777152.632117.111103.44683.36192.07968.642101.73283.55583.555
Other Expenses 0.499-7.483-0.007-3.701-0.053-0.4814.818-7.468-17.90317.7371.669-0.279-0.0442.714-0.01-0.04-1.3380.063-0.4921.4561.27300
Operating Expenses 192.057253.521203.193209.862128.389197.806215.888183.187195.422176.723189.059189.841190.463176.305167.977133.386138.169109.95696.517113.88310789.70589.705
Operating Income 37.94252.26329.01549.82344.31169.09677.92445.33982.67157.12854.91751.31648.2545.09247.79641.19138.57343.14734.52828.09630.71928.18428.184
Operating Income Ratio 0.1080.1220.0870.1340.1730.1520.0960.0660.1240.0950.0870.0840.0820.0860.0870.080.080.0980.0760.0630.0730.0720.072
Total Other Income Expenses Net 6.435-0.246-0.0072.57-0.053-0.4810.773-0.126-0.0590.039-0.086-0.279-0.0442.714-0.01-0.04-0.0290.063-0.4921.4561.2730.0250.025
Income Before Tax 44.37759.87529.00865.45144.25868.61578.03445.21382.61257.16754.83151.03848.20647.80647.78641.15138.54343.2134.03629.55231.99330.0430.04
Income Before Tax Ratio 0.1270.140.0870.1770.1720.150.0960.0660.1240.0950.0870.0840.0820.0910.0870.0790.080.0980.0750.0660.0760.0770.077
Income Tax Expense 4.7139.3981.5535.4572.5573.62711.8936.51410.2336.1247.7044.1536.4485.9136.0955.6974.9276.251.3435.894.6254.625
Net Income 41.54947.05930.37255.29840.24664.98866.14238.69972.3851.04347.12746.88541.75841.89341.69135.45433.61637.01129.03628.20926.10325.41525.415
Net Income Ratio 0.1180.110.0910.1490.1570.1430.0810.0560.1090.0850.0750.0770.0710.080.0760.0680.0690.0840.0640.0630.0620.0650.065
EPS 0.220.250.190.350.260.410.420.20.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
EPS Diluted 0.220.250.190.350.260.410.420.20.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
EBITDA 44.47179.73931.12779.77557.83479.18188.90432.34290.61666.82966.06364.58560.57355.21254.99945.29141.79947.07438.21132.37336.0731.88131.881
EBITDA Ratio 0.1270.1670.0930.1710.1670.1610.1010.0470.1280.0980.0920.0870.0830.090.0910.0860.0890.0990.080.0720.0880.0810.081